Step Pharma SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Step Pharma SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11126
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Step Pharma SAS (Step Pharma) is a biotechnology company that strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase 1 (CTPS1) for the enhanced treatment of an array of auto-immune diseases and lymphoproliferative cancers. Its CTPS1 inhibitors have the potential to achieve selective modulation of specific immune cells such as T and B cells, which improves efficacy and therapeutic index. It works in partnership with other biotechnology companies to commercialize its modulator programs. The company is a spin-off of Institut Des Maladies Genetiques (Imagine Institute), France. Step Pharma is headquartered in Paris, France.

Step Pharma SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Step Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Step Pharma SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Step Pharma Raises Additional USD10.1 Million in Series A Financing 10
Step Pharma Raises USD6.4 Million in Series A Financing 12
Equity Offering 13
Step Pharma Spin Off from Imagine Institute 13
Step Pharma SAS – Key Competitors 14
Step Pharma SAS – Key Employees 15
Step Pharma SAS – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Step Pharma SAS, Pharmaceuticals & Healthcare, Key Facts 2
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Step Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Step Pharma SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Step Pharma Raises Additional USD10.1 Million in Series A Financing 10
Step Pharma Raises USD6.4 Million in Series A Financing 12
Step Pharma Spin Off from Imagine Institute 13
Step Pharma SAS, Key Competitors 14
Step Pharma SAS, Key Employees 15

List of Figures
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Step Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Step Pharma SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kohinoor Energy Limited (KOHE):企業の財務・戦略的SWOT分析
    Kohinoor Energy Limited (KOHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SM Energy Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    SM Energy Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary SM Energy Co (SM Energy) is an independent upstream oil and gas company. It carries out the acquisition, exploration, development, and production of crude oil, natural gas and natural gas liquids (NGLs) …
  • Bureau Veritas SA:企業の戦略・SWOT・財務情報
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Strategic Metals Ltd (SMD):企業の財務・戦略的SWOT分析
    Summary Strategic Metals Ltd (Strategic Metals) is a mining and mineral exploration company that acquires, explores, produces, and develops gold properties across Canada. Its portfolio covers a broad suite of metals, including gold, silver, lead, zinc, copper, tin, tungsten, vanadium and lithium. It …
  • Xodus Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Xodus Group Ltd (Xodus) is a provider of engineering and advisory services. The company offers services such as exploration and appraisal, development, projects, asset support, decommissioning and advisory services. Its exploration services comprise regional studies, basin modelling, acreage …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • MIE Holdings Corp (1555):石油・ガス:M&Aディール及び事業提携情報
    Summary MIE Holdings Corp (MIEH), a subsidiary of Far East Energy Ltd is an oil and gas company that carries out exploration, development and production activities. The company operates Daan, Moliqing and Miao 3 oilfields in the Songliao Basin. Its Daan oilfield is located in Daan City that covers a …
  • China Southern Airlines Company Limited:企業の戦略・SWOT・財務情報
    China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Kratos Defense & Security Solutions, Inc.:企業のM&A・事業提携・投資動向
    Kratos Defense & Security Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kratos Defense & Security Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Absorption Systems LP-製薬・医療分野:企業M&A・提携分析
    Summary Absorption Systems LP (Absorption Systems) is a pre-clinical contract research organization that develops and implements research tools. The organization carries out preclinical testing of drugs, biologics, and medical devices. It develops and implements research tools to predict human outco …
  • GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Spherix Inc (SPEX)
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Graphic Packaging Holding Company:企業の戦略・SWOT・財務情報
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polyme …
  • Safeguard Scientifics Inc (SFE):企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …
  • Aeon Co., Ltd.:企業の戦略・SWOT・財務情報
    Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • AVT McCormick Ingredients Pvt. Ltd.:企業の戦略・SWOT・財務情報
    AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Infigen Energy Ltd (IFN):電力:M&Aディール及び事業提携情報
    Summary Infigen Energy Ltd (IEL) is a major renewable energy company that develops, builds, owns and operates renewable energy generation assets in Australia. It owns interests in several wind farms and a solar farm across New South Wales, South Australia and Western Australia. IEL sells the produce …
  • Viridian Group Investments Ltd:企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆